CLDX: Celldex Therapeutics Inc Sotuvga nisbatan narx
Celldex Therapeutics (CLDX) tibbiyot markazlari bilan hamkorlikda maqsadli yallig'lanishga qarshi terapiyalarni ishlab chiqmoqda. Kompaniyaning P/S koeffitsiyentini kuzatish uning bozor qiymatini daromadga nisbatan aniqlaydi, bunda 13951.10 ushbu parametrning joriy holatini belgilaydi. Narxlar dinamikasi barzolvolimab sinovlariga va tadqiqot va ishlanmalar (R&D) xarajatlariga bog'liq. Ishlab chiqarish barqarorligi qat'iy sovuq zanjir nazorati va xalqaro biomaterial yetkazib beruvchilarning diversifikatsiyasi orqali ta'minlanadi.
Celldex (CLDX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Celldex Therapeutics|CLDX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Celldex Corp|CLDX - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Celldex|CLDX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Celldex Therapeutics|Shoshilinch likvidlik koeffitsiyenti celldex.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CLDX - Sof daromad|Kutilayotgan sof daromad Celldex Therapeutics|CLDX - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati Celldex Therapeutics Inc|CLDX - PEG multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Celldex|CLDX - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Celldex Therapeutics|CLDX - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi celldex.com|CLDX - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Celldex Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:celldex.com (CLDX)
Operatsion daromadning pasayishi xavfi biznesni bozor zarbalariga nisbatan zaif qiladi, biroq yuqori marjali urtikariya terapiyasi antitelalari uchun patent himoyasi Celldex Therapeutics (CLDX) kompaniyasiga sezilarli xavfsizlik zaxirasini taqdim etadi. Sotuvlar nisbatini (price-to-sales ratio) tahlil qilish orqali investor daromadning har bir birligi uchun to'langan bozor premiumini aniqlaydi, bu esa narxlar pasayishi paytida aktivning fundamental past baholanganligi va xavfli qiymat tuzog'i (value trap) o'rtasidagi farqni ajratish imkonini beradi.
Raqobatdosh kompaniyalar
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|Protagonist Corp (PTGX) - Kapitalizatsiyaning daromadga nisbati|IMVT: P/S multiplikatori|Sotuvga nisbatan narx kiniksa.com (KNSA)|Narxning daromadga nisbati Grifols|Narxning daromadga nisbati ADPT|Narxning daromadga nisbati Aurinia Pharma (AUPH)|Narxning daromadga nisbati BCRX (BioCryst Corp)|P/S multiplikatori VERA (Vera Therapeutics, Inc.)|DNTH: Kapitalizatsiya va daromad nisbati|Pharvaris - P/S multiplikatori|Sotuvga nisbatan narx AbCellera Biologics Inc.|TRML (Tourmaline Corp) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiya va daromad nisbati PGEN|Kapitalizatsiyaning daromadga nisbati PHAR|NKTR: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati UPB (Upstream Bio)|Kapitalizatsiyaning sotish hajmiga nisbati ZBIO|P/S multiplikatori IMNM (Immunome Corp)|Bozor kapitallashuvining daromadga nisbati GOSS|KalVista Pharmaceuticals - P/S multiplikatori|Sotuvga nisbatan narx septerna.com|Pieris Pharmaceuticals, Inc. (PVLA) - Narxning daromadga nisbati|Savara Inc - Bozor kapitallashuvining daromadga nisbati|RIGL (Rigel Pharmaceuticals Inc) - P/S multiplikatori|P/S multiplikatori AnaptysBio Inc.|Narxning daromadga nisbati Astria Therapeutics (ATXS)|ENGN: Narxning sotuvga nisbati|P/S multiplikatori RAPT (RAPT Therapeutics)|Aerovate Therapeutics, Inc. (JBIO) - Sotuvga nisbatan narx|ACRS: Kapitalizatsiyaning daromadga nisbati|KYTX - P/S multiplikatori|TLSA (Tiziana Life Sciences) - Kapitalizatsiyaning daromadga nisbati|CABA: Kapitalizatsiyaning sotish hajmiga nisbati|VTYX (Ventyx Biosciences, Inc.) - P/S multiplikatori|Theratechnologies, Inc. (THTX) - Narx/daromad koeffitsiyenti|P/S multiplikatori AVTX|Kapitalizatsiyaning daromadga nisbati Eledon Pharmaceuticals, Inc ELDN|Narxning daromadga nisbati Agenus AGEN|Narx/daromad koeffitsiyenti climbbio.com (CLYM)|Zura Bio - P/S multiplikatori|aTyr Pharma Inc (ATYR) - Kapitalizatsiyaning daromadga nisbati|adagene.com (ADAG) - Narxning daromadga nisbati|IMA (Ikena Oncology) - Narxning daromadga nisbati|STTK (Shattuck Labs Inc) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati EQ (Equillium Bio)|Kapitalizatsiyaning daromadga nisbati CNTB (Connect Biopharma)|immunic-therapeutics.com - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati Atara Bio ATRA|IFRX (InflaRx NV) - Narxning sotuvga nisbati|X4 Pharmaceuticals - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACET (Adicet Bio)|CELU: P/S multiplikatori|INmune Bio Inc (INMB) - P/S multiplikatori|Narxning daromadga nisbati Barinthus Bio|KZR: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati SAB Biotherapeutics (SABS)|Kapitalizatsiyaning daromadga nisbati akaritx.com AKTX|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd.)|P/S multiplikatori Q32 Bio Inc QTTB|GOVX: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati EDSA (Edesa Biotech Corp)|IBIO: P/S multiplikatori|CARM - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati XTL Biopharmaceuticals Ltd.|Kapitalizatsiyaning daromadga nisbati Bolt Bio (BOLT)|Narxning daromadga nisbati HCW Biologics Inc. (HCWB)|Kapitalizatsiyaning daromadga nisbati aptevotherapeutics.com APVO|AIM ImmunoTech Inc. - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Aditxt Inc. ADTX|GRI - Narxning daromadga nisbati|XRTX (XORTX Therapeutics Inc) - Kapitalizatsiya va daromad nisbati|HIND: P/S multiplikatori|Sotuvga nisbatan narx Revelation Biosciences Corp (REVB)|INDP (Indaptus Therapeutics) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati scinai.com (SCNI)|P/S multiplikatori CALI|AFMD - Sotuvga nisbatan narx|Narxning daromadga nisbati Allakos ALLK|HOOKIPA Pharma, Inc. - Narxning daromadga nisbati|IGMS - Narxning daromadga nisbati|ITOS: Narxning daromadga nisbati|OCEA: P/S multiplikatori|Kapitalizatsiya va daromad nisbati TCBP|THRD (Third Harmonic Bio, Inc) - P/S multiplikatori
